Short-term anatomical outcome of Verteporfin photodynamic therapy for treatment-naiive chronic central serous chorioretinopathy as a predictor for long-term anatomical outcome
This retrospective study of 58 eyes with treatment-naive chronic central serous chorioretinopathy suggests that the presence of subretinal fluid at the 3-month follow-up after a single session of verteporfin photodynamic therapy predicts persistent fluid and the need for further treatment, as no eyes with initial fluid later achieved a dry macula.